Henry Spencer, M.D.
NPI 1245307487 · Dermatology Physician · Torrington, CT
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1245307487
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 029055 (CT)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
2,090 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 977 | $7 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 303 | $65 |
| Biopsy of Related Skin Growth, First Growth11102 | 235 | $106 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 229 | $59 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 219 | $95 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Mometasone Furoate | 79 | 42 |
| Mupirocin | 52 | 29 |
| Metronidazole | 19 | 11 |
| Triamcinolone Acetonide | 17 | 12 |
| Hydroxyzine Hcl | 14 | — |
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented | 14 | — |
| Ketoconazole | 12 | — |
| Erythromycin Base in Ethanolbrand: Ery |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-11-30
- Last updated
- 2023-01-09
- Certified
- 2023-01-09
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.